How is the ExaMD cognitive AI app used?

Users simply have a 'free conversation' for about one minute using a smartphone, and the AI analyzes the voice to assess cognitive function.

How accurate is this app?

In clinical research stages, it has demonstrated a diagnostic accuracy of approximately 95%.

When will it be available for practical use?

Clinical trials are underway with the goal of obtaining manufacturing and marketing approval and launching it within FY2026.

AI News NQ Analysis

ExaMD, an ExaWizards Group Company, Completes First Patient Registration in Clinical Trial for AI-Driven Cognitive Diagnostic Support App

NQ Score 81/100

N1 Content Completeness 9

AI Summary (NQ-processed)

ExaMD Inc. has completed the First Patient In (FPI) for a clinical trial of its 'Cognitive Function AI Diagnostic Support App,' which analyzes cognitive function from smartphone voice data. Designated for 'Priority Review' by the Ministry of Health, Labour and Welfare in February 2025, the company aims for regulatory approval and launch within FY2026.

AI Analysis

Frequently Asked Questions

Q: How is the ExaMD cognitive AI app used?: A: Users simply have a 'free conversation' for about one minute using a smartphone, and the AI analyzes the voice to assess cognitive function.
Q: How accurate is this app?: A: In clinical research stages, it has demonstrated a diagnostic accuracy of approximately 95%.
Q: When will it be available for practical use?: A: Clinical trials are underway with the goal of obtaining manufacturing and marketing approval and launching it within FY2026.